Maplight Therapeutics files Form 144 for common stock

Maplight Therapeutics, Inc. submitted a Form 144 notice related to proposed sales of Common Stock through Jefferies LLC.

Rhea-AI Filing Summary

Maplight Therapeutics, Inc. submitted a Form 144 notice related to proposed sales of Common Stock through Jefferies LLC. The filing lists trade details and several RSU grants with grant dates and share counts. Quantities shown include 49,365.54 (value or shares field) and grant-related share amounts of 1,668, 853, and 3,012.

The filing names Jefferies LLC as the broker-dealer and references 04/15/2026 and NASDAQ as the market; timing and proceeds treatment are those stated in the form.

Insights

Capital markets compliance

TL;DR: Form 144 lists proposed resale of Common Stock through a broker-dealer with several RSU grant entries.

The notice documents an affiliate resale pathway by naming Jefferies LLC as the broker-dealer and listing share-related entries and grant dates. This is a regulatory disclosure that permits sales under Rule 144 mechanics when conditions are met.

Relevant dependencies include holding/holding-period and Rule 144 conditions; the excerpt provides grant dates (07/30/2023, 11/09/2023, 05/02/2024) and per-grant share counts, which are the key items to reconcile with transferability rules in future filings.

Key Figures

Broker reference: Jefferies LLC Market listed: NASDAQ Form date field: 04/15/2026 +4 more

7 metrics

Broker reference Jefferies LLC Named broker-dealer on the Form 144

Market listed NASDAQ Market referenced in the filing

Form date field 04/15/2026 Date shown in the securities table

Quantity field 49,365.54 Value or share field shown in the excerpt

RSU grant (07/30/2023) 1,668 shares Restricted Stock Unit Grant dated <date>07/30/2023</date>

RSU grant (11/09/2023) 853 shares Restricted Stock Unit Grant dated <date>11/09/2023</date>

RSU grant (05/02/2024) 3,012 shares Restricted Stock Unit Grant dated <date>05/02/2024</date>

Key Terms

Form 144, Restricted Stock Unit Grant, broker-dealer, proposed resale

4 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Unit Grant financial

"Restricted Stock Unit Grant | Maplight Therapeutics, Inc."

broker-dealer financial

"Jefferies LLC 520 Madison Ave 4th Fl New York"

A broker-dealer is a licensed firm or individual that both executes trades on behalf of clients (acting as a broker) and buys or sells securities for its own account (acting as a dealer). Investors care because broker-dealers provide the plumbing of markets — they place orders, hold or move cash and securities, offer research or advice, and their stability and fees directly affect trade execution, costs, and the safety of client funds; think of them as a combined travel agent and taxi for your investments.

proposed resale regulatory

"Securities To Be Sold"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Maplight Therapeutics (MPLT) Form 144 mean?

A Form 144 notifies the SEC of a proposed sale of restricted or control securities by an affiliate. It names the broker-dealer, lists grant dates and quantities, and signals an intent to sell under Rule 144 conditions rather than an immediate completed sale.

Which broker is listed for the MPLT proposed sale?

The filing lists Jefferies LLC as the broker-dealer for the proposed transactions. The form ties the resale notice to Jefferies and indicates NASDAQ as the referenced market, with a date of 04/15/2026 shown in the excerpt.

What RSU grant details are disclosed in the filing for MPLT?

The excerpt shows three Restricted Stock Unit grants with dates and share counts: 07/30/2023 (1,668 shares), 11/09/2023 (853 shares), and 05/02/2024 (3,012 shares). These figures are listed in the securities table.

Does the Form 144 confirm completed sales for MPLT?

No; Form 144 records a proposed resale notice rather than completed transactions. The form lists the intended broker and securities to be sold; actual sales, amounts received, and timing would appear in subsequent trade confirmations or filings when executed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/15/2026 - 04:11 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001789970
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	MapLight Therapeutics, Inc.
SEC File Number	001-42914
Address of Issuer	800 CHESAPEAKE DRIVE REDWOOD CITY CALIFORNIA 94063
Phone	650-839-4360
Name of Person for Whose Account the Securities are To Be Sold	Hanson Kristopher
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Jefferies LLC 520 Madison Ave 4th Fl New York NY 10022	1827	49365.54	42440000	04/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/30/2023	Restricted Stock Unit Grant	Maplight Therapeutics, Inc.			1668	07/30/2023	N/A
Common	11/09/2023	Restricted Stock Unit Grant	Maplight Therapeutics, Inc.			853	11/09/2023	N/A
Common	05/02/2024	Restricted Stock Unit Grant	Maplight Therapeutics, Inc.			3012	05/02/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	04/15/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Kristopher Hanson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)